110 related articles for article (PubMed ID: 21700115)
1. Quiescent posterior capsule trauma after intravitreal injection: implications for the cataract surgeon.
Khalifa YM; Pantanelli SM
J Cataract Refract Surg; 2011 Jul; 37(7):1364. PubMed ID: 21700115
[No Abstract] [Full Text] [Related]
2. Cataract with posterior capsule rupture following intravitreal injection.
Shaikh N; Kumar V; Beniwal A
Indian J Ophthalmol; 2019 Oct; 67(10):1729. PubMed ID: 31546538
[No Abstract] [Full Text] [Related]
3. Inadvertent Intra-Lenticular Injection of Anti-Vascular Endothelial Growth Factor.
Singh SR; Kaur S; Ram J
Ophthalmology; 2020 Sep; 127(9):1233. PubMed ID: 32828194
[No Abstract] [Full Text] [Related]
4. Toxic vitreitis outbreak after intravitreal injection.
Deka S
Retina; 2011 Mar; 31(3):631; author reply 631. PubMed ID: 21336079
[No Abstract] [Full Text] [Related]
5. Intravitreal bevacizumab for parapapillary choroidal neovascularization due to exudative age-related macular degeneration.
Jonas JB; Tao Y; Rensch F
Acta Ophthalmol; 2011 Feb; 89(1):e105-7. PubMed ID: 20064119
[No Abstract] [Full Text] [Related]
6. Combined cataract extraction and intravitreal bevacizumab in eyes with choroidal neovascularization resulting from age-related macular degeneration.
Furino C; Ferrara A; Cardascia N; Besozzi G; Alessio G; Sborgia L; Boscia F
J Cataract Refract Surg; 2009 Sep; 35(9):1518-22. PubMed ID: 19683147
[TBL] [Abstract][Full Text] [Related]
7. Re: Changes of intraocular pressure after intravitreal injection of bevacizumab (Avastin).
Utman SA; Dhillon B
Retina; 2008 Apr; 28(4):667; author reply 667-8. PubMed ID: 18398378
[No Abstract] [Full Text] [Related]
8. Management of cataract caused by inadvertent capsule penetration during intravitreal injection of ranibizumab.
Saeed MU; Prasad S
J Cataract Refract Surg; 2009 Nov; 35(11):1857-9. PubMed ID: 19878815
[TBL] [Abstract][Full Text] [Related]
9. 1 - year follow-up after intravitreal bevacizumab alone and in combination with photodynamic therapy for AMD and PCV.
Forte R
Acta Ophthalmol; 2011 Jun; 89(4):e373. PubMed ID: 21040503
[No Abstract] [Full Text] [Related]
10. Accuracy of 3 imaging modalities for evaluation of the posterior lens capsule in traumatic cataract.
Tabatabaei A; Hasanlou N; Kheirkhah A; Mansouri M; Faghihi H; Jafari H; Arefzadeh A; Moghimi S
J Cataract Refract Surg; 2014 Jul; 40(7):1092-6. PubMed ID: 24836968
[TBL] [Abstract][Full Text] [Related]
11. Charles Bonnet syndrome (visual hallucinations) after intravitreal avastin injection for age-related macular degeneration.
Tan CS; Sanjay S; Au Eong KG
Am J Ophthalmol; 2007 Aug; 144(2):330; author reply 330-1. PubMed ID: 17659977
[No Abstract] [Full Text] [Related]
12. Regression of neovascular posterior capsule vessels by intravitreal bevacizumab.
Eren E; Küçükerdönmez C; Yilmaz G; Akova YA
J Cataract Refract Surg; 2007 Jun; 33(6):1113-5. PubMed ID: 17531712
[TBL] [Abstract][Full Text] [Related]
13. Characterization of sterile intraocular inflammatory responses after intravitreal bevacizumab injection.
Chong DY; Anand R; Williams PD; Qureshi JA; Callanan DG
Retina; 2010 Oct; 30(9):1432-40. PubMed ID: 20559156
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal bevacizumab for exudative age-related macular degeneration: effect on different subfoveal membranes.
Tao Y; Jonas JB
Retina; 2010 Oct; 30(9):1426-31. PubMed ID: 20539255
[TBL] [Abstract][Full Text] [Related]
15. Phacoemulsification with intravitreal bevacizumab injection in diabetic patients with macular edema and cataract.
Akinci A; Batman C; Ozkilic E; Altinsoy A
Retina; 2009; 29(10):1432-5. PubMed ID: 19898181
[TBL] [Abstract][Full Text] [Related]
16. Management of iatrogenic crystalline lens injury occurred during intravitreal injection.
Erdogan G; Gunay BO; Unlu C; Gunay M; Ergin A
Int Ophthalmol; 2016 Aug; 36(4):527-30. PubMed ID: 26631401
[TBL] [Abstract][Full Text] [Related]
17. Retinal pigment epithelium tears after intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration.
Ronan SM; Yoganathan P; Chien FY; Corcóstegui IA; Blumenkranz MS; Deramo VA; Elner SG; Fastenberg DA; Johnson MW; López M; Mateo C; Moshfeghi DM; Navarro R; Rosenblatt BJ; Sanislo SR; Saxe SJ; Zacks DN
Retina; 2007 Jun; 27(5):535-40. PubMed ID: 17558313
[TBL] [Abstract][Full Text] [Related]
18. Comparing ranibizumab with bevacizumab.
Biswas P; Sengupta S; Choudhary R; Home S; Paul A; Sinha S
Ophthalmology; 2011 Mar; 118(3):600-600.e2. PubMed ID: 21376243
[No Abstract] [Full Text] [Related]
19. Third nerve palsy following intravitreal anti-VEGF therapy for bilateral neovascular age-related macular degeneration.
Micieli JA; Santiago P; Brent MH
Acta Ophthalmol; 2011 Feb; 89(1):e99-100. PubMed ID: 19925526
[No Abstract] [Full Text] [Related]
20. Intravitreal bevacizumab.
Lucas RS; McKee HD; Lee LR
Ophthalmology; 2007 Feb; 114(2):400; author reply 400-1. PubMed ID: 17270701
[No Abstract] [Full Text] [Related]
[Next] [New Search]
